Immune-mediated colitis associated with ocrelizumab: A new safety risk.

Tiffany Kim,Allen Brinker,David Croteau, Paul R Lee,Laura E Baldassari, Jessica Stevens, Alice Hughes, Juli Tomaino, Arushi deFonseka,Tara Altepeter,Cindy M Kortepeter

Multiple sclerosis (Houndmills, Basingstoke, England)（2023）

引用 0|浏览2

暂无评分

摘要

This case series highlights ocrelizumab induced immune-mediated colitis that can be clinically severe and potentially life-threatening. Based on the findings of this review, the ocrelizumab Prescribing Information was amended to include immune-mediated colitis in the Warnings and Precautions section.

查看译文

关键词

ocrelizumab,colitis,immune-mediated

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要